Biostax Corp.
BTAX
$0.01
$0.00111.11%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -31.56% | 68.00% | -170.96% | 22.89% | -21.17% |
| Total Depreciation and Amortization | -- | -- | 0.00% | 2.99% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 1,654.50% | -73.33% | 0.00% |
| Change in Net Operating Assets | 25.00% | -41.98% | 41.07% | 1,191.04% | 309.38% |
| Cash from Operations | 134.20% | -133.54% | 1,345.05% | 103.54% | -18.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -178.24% | 119.41% | -462.50% | -108.09% | 97.67% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -178.24% | 119.38% | -463.33% | -108.09% | 97.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.42% | -209.49% | 296.12% | 26.70% | 84.76% |
